Skip to main content

Vivos Inc Files Critical Patent For Hydrogel Electron Beam Sterilization

Written by Customer Service on . Posted in Public Companies.

Kennewick, WA, Sept. 03, 2025 (GLOBE NEWSWIRE) — Vivos Inc. (OTCQB: RDGL) Vivos Inc filed a provisional patent No.: 63/873,014 – STERILE THERMOGELS

Vivos Inc. is pleased to announce the successful validation of a new electron beam (E-Beam) sterilization process for our hydrogel, marking a culmination of nearly a year of testing and validation of a process that was only viable because of the unique characteristics of our hydrogel. The validation was carried out under ISO 11137 by an international medical device accredited organization. Vivos applies these same high standards to both human (Radiogel®) and animal (Isopet®) therapies.

The E-Beam sterilization process is reproduceable and more reliable than our current filtration process, achieving a sterility assurance level of 10-6, which is the most rigorous sterility level; meaning there is a one in a million chance of a viable microorganism surviving, and it is the standard for critical medical devices that enter the body or compromised tissues, ensuring patient safety by minimizing infection risk.

Beyond the clinical advantages, the process is more cost-effective, improves production yield, and meaningfully enhances scalability as we prepare for commercial growth. The ability to efficiently produce and distribute sterile hydrogel and PrecisionGel for therapeutic agent dispersal worldwide, supports Vivos’ strategic path toward broader market penetration.

Importantly, the process will also drive greater manufacturing efficiency for IsoPet®, our animal health therapy, enabling more consistent supply and cost-effective production to meet growing veterinary demand. This dual benefit—advancing both human and animal health divisions—positions Vivos for stronger revenue opportunities while reinforcing our competitive differentiator through intellectual property protection.

Michael K. Korenko, Sc.D.

President & CEO, Vivos Inc.
Email: MKorenko@RadioGel.com
Follow Vivos Inc. on X (Twitter): @VivosIncUSA
Learn more about RadioGel® and IsoPet® at www.VivosInc.com

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, identified by terms such as “will,” “expects,” “plans,” “anticipates,” and “intends.” These statements involve risks and uncertainties that may cause actual results to differ materially, including challenges in executing business strategies, economic conditions, competition, regulatory changes, delays in clinic certifications, and other factors beyond Vivos Inc.’s control. For a detailed discussion of these risks, refer to the company’s filings with the Securities and Exchange Commission.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.